RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Experimental Neoplasms
Accession: DOID:9002170
browse the term
Definition: Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.
Synonyms: exact_synonym: Experimental Neoplasm
primary_id: MESH:D009374
For additional species annotation, visit the
Alliance of Genome Resources .
GViewer not supported for the selected species.
G
Abl1
ABL proto-oncogene 1, non-receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19878872
NCBI chrNW_004955513:652,048...799,182
Ensembl chrNW_004955513:653,252...799,239
G
Ahr
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9496914
NCBI chrNW_004955410:20,428,531...20,459,482
Ensembl chrNW_004955410:20,428,546...20,456,836
G
Arl6ip5
ADP ribosylation factor like GTPase 6 interacting protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29545876
NCBI chrNW_004955421:18,747,729...18,766,559
Ensembl chrNW_004955421:18,747,729...18,766,408
G
Arnt
aryl hydrocarbon receptor nuclear translocator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9496914
NCBI chrNW_004955588:159,462...233,047
Ensembl chrNW_004955588:159,462...233,047
G
Axl
AXL receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26206560
NCBI chrNW_004955555:189,445...218,509
Ensembl chrNW_004955555:189,174...218,565
G
Bcr
BCR activator of RhoGEF and GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19878872
NCBI chrNW_004955455:7,598,794...7,727,386
Ensembl chrNW_004955455:7,598,794...7,727,386
G
Braf
B-Raf proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chrNW_004955494:2,567,238...2,712,708
G
Bsg
basigin (Ok blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21165561
NCBI chrNW_004955495:7,148,806...7,156,296
G
Ccnd1
cyclin D1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20932960
NCBI chrNW_004955422:16,449,921...16,462,676
Ensembl chrNW_004955422:16,448,770...16,463,300
G
Cdh1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27224422
NCBI chrNW_004955484:7,782,409...7,861,082
Ensembl chrNW_004955484:7,782,772...7,860,967
G
Cdk4
cyclin dependent kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20932960
NCBI chrNW_004955458:5,457,927...5,460,718
Ensembl chrNW_004955458:5,453,732...5,460,718
G
Ctcf
CCCTC-binding factor
ISO
human breast cancer cells in mouse model
RGD
PMID:21896759
RGD:151356745
NCBI chrNW_004955484:9,041,226...9,092,924
Ensembl chrNW_004955484:9,042,524...9,064,927
G
Ddr1
discoidin domain receptor tyrosine kinase 1
treatment
ISO
human cancer cells in mouse model
RGD
PMID:26719540
RGD:11520844
NCBI chrNW_004955583:820,893...838,515
Ensembl chrNW_004955583:820,931...841,654
G
Eno2
enolase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22613180
NCBI chrNW_004955413:4,498,625...4,506,769
Ensembl chrNW_004955413:4,498,625...4,506,769
G
Erbb2
erb-b2 receptor tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14612517
NCBI chrNW_004955451:14,442,816...14,456,009
Ensembl chrNW_004955451:14,442,816...14,459,379
G
Ergic3
ERGIC and golgi 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27588471
NCBI chrNW_004955422:25,884,138...25,893,237
Ensembl chrNW_004955422:25,884,080...25,893,236
G
Esrra
estrogen related receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34524571
NCBI chrNW_004955422:20,768,450...20,775,205
Ensembl chrNW_004955422:20,768,450...20,787,451
G
F2r
coagulation factor II thrombin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374729
NCBI chrNW_004955425:24,144,905...24,164,498
G
Hdac6
histone deacetylase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34524571
NCBI chrNW_004955543:348,314...378,391
Ensembl chrNW_004955543:348,019...378,071
G
Hgf
hepatocyte growth factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21273587
NCBI chrNW_004955410:4,114,280...4,181,953
Ensembl chrNW_004955410:4,114,778...4,182,058
G
Hif1a
hypoxia inducible factor 1 subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28574600
NCBI chrNW_004955466:8,000,311...8,022,497
Ensembl chrNW_004955466:8,000,044...8,022,497
G
Hras
HRas proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3433577 PMID:11552296 PMID:26558449
NCBI chrNW_004955476:11,508,446...11,510,333
Ensembl chrNW_004955476:11,508,126...11,510,333
G
Hrh2
histamine receptor H2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:6224980
NCBI chrNW_004955408:28,186,316...28,225,146
Ensembl chrNW_004955408:28,186,249...28,229,411
G
Ifnb1
interferon beta 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2297754
NCBI chrNW_004955434:23,301,623...23,302,304
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15711825
NCBI chrNW_004955458:14,643,333...14,648,020
Ensembl chrNW_004955458:14,643,313...14,648,045
G
Il12a
interleukin 12A
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17332360
NCBI chrNW_004955448:10,611,131...10,617,911
G
Il12b
interleukin 12B
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17332360
NCBI chrNW_004955408:13,302,506...13,316,300
Ensembl chrNW_004955408:13,304,219...13,312,620
G
Il2
interleukin 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:1949363 PMID:3495671 PMID:22306178
NCBI chrNW_004955428:18,163,010...18,168,157
Ensembl chrNW_004955428:18,162,467...18,168,265
G
Itgav
integrin subunit alpha V
treatment
ISO
human cells in rat model
RGD
PMID:20841470
RGD:152998949
NCBI chrNW_004955403:11,588,536...11,669,809
Ensembl chrNW_004955403:11,592,339...11,659,297
G
Kif11
kinesin family member 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17974955
NCBI chrNW_004955425:764,382...804,856
Ensembl chrNW_004955425:763,868...804,583
G
Kras
KRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9205081 PMID:10813127 PMID:21311774 PMID:25851810 PMID:26390243
NCBI chrNW_004955413:20,298,852...20,328,756
Ensembl chrNW_004955413:20,298,824...20,328,758
G
Ldha
lactate dehydrogenase A
ISO
RGD
PMID:11085542
RGD:1600281
NCBI chrNW_004955414:33,087,745...33,100,846
G
Lect2
leukocyte cell derived chemotaxin 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30453282
NCBI chrNW_004955408:31,016,955...31,068,998
Ensembl chrNW_004955408:31,016,815...31,025,093
G
Mapk7
mitogen-activated protein kinase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29507229
NCBI chrNW_004955467:381,801...387,078
Ensembl chrNW_004955467:378,156...386,532
G
Nqo1
NAD(P)H quinone dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:9496914 PMID:21034357
NCBI chrNW_004955484:7,012,373...7,028,182
Ensembl chrNW_004955484:7,012,506...7,027,604
G
Nras
NRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9205081
NCBI chrNW_004955435:18,001,517...18,009,105
Ensembl chrNW_004955435:18,001,517...18,009,103
G
Parg
poly(ADP-ribose) glycohydrolase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33044785
NCBI chrNW_004955556:435,264...539,935
Ensembl chrNW_004955556:435,027...535,941
G
Pcna
proliferating cell nuclear antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20932960
NCBI chrNW_004955415:15,744,601...15,748,910
Ensembl chrNW_004955415:15,744,601...15,749,673
G
Polr1h
RNA polymerase I subunit H
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16609701
NCBI chrNW_004955583:191,252...195,563
Ensembl chrNW_004955583:191,564...195,358
G
Prl
prolactin
treatment
ISO
RGD
PMID:26983879
RGD:152177690
NCBI chrNW_004955483:4,495,257...4,503,377
G
Prnp
prion protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21265952
NCBI chrNW_004955415:15,442,313...15,454,644
Ensembl chrNW_004955415:15,442,313...15,454,644
G
Puf60
poly(U) binding splicing factor 60
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21435101
NCBI chrNW_004955454:2,482,968...2,497,339
Ensembl chrNW_004955454:2,482,968...2,497,339
G
Rb1
RB transcriptional corepressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27137931
NCBI chrNW_004955431:1,960,765...2,124,576
Ensembl chrNW_004955431:1,960,661...2,124,576
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20932960
NCBI chrNW_004955422:19,602,930...19,612,263
Ensembl chrNW_004955422:19,603,345...19,611,516
G
Rictor
RPTOR independent companion of MTOR complex 2
disease_progression
ISO
RGD
PMID:24244675
RGD:152995458
NCBI chrNW_004955426:23,468,112...23,582,587
Ensembl chrNW_004955426:23,468,112...23,582,587
G
Sparc
secreted protein acidic and cysteine rich
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20164124
NCBI chrNW_004955408:6,100,123...6,122,460
Ensembl chrNW_004955408:6,099,003...6,122,459
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21852811
NCBI chrNW_004955474:1,914,477...1,922,025
Ensembl chrNW_004955474:1,913,829...1,922,016
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29507229
NCBI chrNW_004955451:16,320,326...16,348,505
Ensembl chrNW_004955451:16,319,904...16,357,687
G
Stim1
stromal interaction molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27863410
NCBI chrNW_004955414:19,652,990...19,849,353
Ensembl chrNW_004955414:19,652,990...19,847,964
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:1674182 PMID:3361654 PMID:12627504
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
G
Tnfsf10
TNF superfamily member 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17767197 PMID:24345465
NCBI chrNW_004955420:2,550,392...2,566,448
Ensembl chrNW_004955420:2,549,142...2,566,564
G
Tob1
transducer of ERBB2, 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12756225
NCBI chrNW_004955451:10,950,270...10,963,183
G
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12756225 PMID:27137931
NCBI chrNW_004955467:9,241,391...9,256,716
Ensembl chrNW_004955467:9,252,130...9,255,928
G
Tp63
tumor protein p63
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25739959
NCBI chrNW_004955420:18,178,639...18,384,786
Ensembl chrNW_004955420:18,176,155...18,384,786
G
Trim47
tripartite motif containing 47
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31981573
NCBI chrNW_004955506:6,379,088...6,383,671
Ensembl chrNW_004955506:6,379,088...6,385,446
G
Uri1
URI1 prefoldin like chaperone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21397856
NCBI chrNW_004955468:7,651,061...7,718,968
Ensembl chrNW_004955468:7,648,456...7,718,074
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:20376344 PMID:20932960 PMID:28574600
NCBI chrNW_004955437:9,527,445...9,541,908
G
Rhob
ras homolog family member B
ISO
RGD
PMID:1710770
RGD:704375
NCBI chrNW_004955469:2,964,968...2,966,998
Ensembl chrNW_004955469:2,965,041...2,965,631
G
C3
complement C3
treatment
ISO
RGD
PMID:16947020
RGD:7401280
NCBI chrNW_004955495:2,796,601...2,824,233
Ensembl chrNW_004955495:2,796,663...2,824,697
G
Coq7
coenzyme Q7, hydroxylase
susceptibility
ISO
RGD
PMID:23166727
RGD:10402105
NCBI chrNW_004955442:3,026,458...3,033,582
Ensembl chrNW_004955442:3,025,484...3,033,582
G
Csf1r
colony stimulating factor 1 receptor
ameliorates
ISO
mouse cell line in a mouse model
RGD
PMID:20008303
RGD:150524291
NCBI chrNW_004955415:4,434,486...4,462,505
Ensembl chrNW_004955415:4,434,453...4,461,751
G
Il18
interleukin 18
treatment
ISO
RGD
PMID:16767432
RGD:8655941
NCBI chrNW_004955412:13,807,361...13,826,007
Ensembl chrNW_004955412:13,806,553...13,825,634
G
Il2
interleukin 2
treatment
ISO
RGD
PMID:9399664
RGD:8663451
NCBI chrNW_004955428:18,163,010...18,168,157
Ensembl chrNW_004955428:18,162,467...18,168,265
G
Irak3
interleukin 1 receptor associated kinase 3
ISO
RGD
PMID:21278795
RGD:36049796
NCBI chrNW_004955458:12,839,995...12,880,285
Ensembl chrNW_004955458:12,846,237...12,879,316
G
Jam3
junctional adhesion molecule 3
ISO
RGD
PMID:15994945
RGD:7488936
NCBI chrNW_004955412:34,901,850...34,967,394
Ensembl chrNW_004955412:34,901,681...34,967,394
G
Lect2
leukocyte cell derived chemotaxin 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30453282
NCBI chrNW_004955408:31,016,955...31,068,998
Ensembl chrNW_004955408:31,016,815...31,025,093
G
Mapk14
mitogen-activated protein kinase 14
ameliorates
ISO
mouse cell line in a mouse model
RGD
PMID:29907597
RGD:151665504
NCBI chrNW_004955437:3,836,331...3,884,083
Ensembl chrNW_004955437:3,838,232...3,884,083
G
Myd88
MYD88 innate immune signal transduction adaptor
treatment
ISO
mouse cell line in a mouse model
RGD
PMID:26111447
RGD:150521531
NCBI chrNW_004955427:25,553,589...25,557,654
Ensembl chrNW_004955427:25,553,589...25,559,138
G
Txnrd1
thioredoxin reductase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16565519
NCBI chrNW_004955405:38,863,762...38,928,615
Ensembl chrNW_004955405:38,903,918...38,927,410
G
Cd40
CD40 molecule
treatment
ISO
RGD
PMID:19269163
RGD:11352683
NCBI chrNW_004955445:11,191,817...11,202,156
Ensembl chrNW_004955445:11,190,603...11,202,093
G
Cd40lg
CD40 ligand
treatment
ISO
RGD
PMID:19269163
RGD:11352683
NCBI chrNW_004955489:8,465,571...8,477,714
Ensembl chrNW_004955489:8,465,164...8,477,746
G
Ceacam20
CEA cell adhesion molecule 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34605108
NCBI chrNW_004955555:1,752,634...1,769,148
Ensembl chrNW_004955555:1,752,080...1,769,846
G
Cbl
Cbl proto-oncogene
treatment
ISO
RGD
PMID:20890046
RGD:11038805
NCBI chrNW_004955412:20,307,011...20,388,539
Ensembl chrNW_004955412:20,307,011...20,388,539
G
Cbx7
chromobox 7
ISO
RGD
PMID:25434821
RGD:11352713
NCBI chrNW_004955413:25,079,627...25,100,039
Ensembl chrNW_004955413:25,086,186...25,100,039
G
Fgfr1
fibroblast growth factor receptor 1
treatment
ISO
RGD
PMID:22781593
RGD:11352669
NCBI chrNW_004955463:14,013,247...14,064,354
Ensembl chrNW_004955463:14,013,247...14,064,111
G
Il1a
interleukin 1 alpha
treatment
ISO
RGD
PMID:2117483
RGD:11051972
NCBI chrNW_004955470:1,527,710...1,538,418
Ensembl chrNW_004955470:1,527,674...1,538,466
G
Lat2
linker for activation of T cells family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32587277
NCBI chrNW_004955456:13,674,190...13,688,611
G
Nras
NRAS proto-oncogene, GTPase
induced
ISO
DNA:transversion mutation, loss of heterozygosity:cds:
RGD
PMID:9142215
RGD:11535063
NCBI chrNW_004955435:18,001,517...18,009,105
Ensembl chrNW_004955435:18,001,517...18,009,103
G
Ptpn11
protein tyrosine phosphatase non-receptor type 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chrNW_004955482:8,934,734...9,031,230
Ensembl chrNW_004955482:8,934,306...9,035,203
G
Abcb11
ATP binding cassette subfamily B member 11
ISO
RGD
PMID:15853769
RGD:1598580
NCBI chrNW_004955449:5,412,958...5,511,629
Ensembl chrNW_004955449:5,412,876...5,512,701
G
Adsl
adenylosuccinate lyase
ISO
protein:increased activity:liver (rat)
RGD
PMID:2937404
RGD:1598766
NCBI chrNW_004955413:26,067,463...26,084,669
Ensembl chrNW_004955413:26,067,516...26,088,527
G
Agps
alkylglycerone phosphate synthase
ISO
RGD
PMID:7407223
RGD:1598794
NCBI chrNW_004955403:19,253,784...19,381,883
Ensembl chrNW_004955403:19,257,501...19,381,901
G
Alas2
5'-aminolevulinate synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chrNW_004955475:2,362,368...2,382,680
Ensembl chrNW_004955475:2,362,118...2,377,864
G
Apoa4
apolipoprotein A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chrNW_004955412:18,158,095...18,160,636
Ensembl chrNW_004955412:18,155,801...18,160,701
G
Apoc2
apolipoprotein C2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chrNW_004955555:2,019,547...2,021,543
Ensembl chrNW_004955555:2,016,217...2,021,830
G
Arid1a
AT-rich interaction domain 1A
disease_progression
ISO
RGD
PMID:26569409
RGD:11344640
NCBI chrNW_004955452:6,068,631...6,120,759
Ensembl chrNW_004955452:6,068,631...6,120,759
G
Arrb2
arrestin beta 2
ISO
mRNA, protein:increased expression:liver (rat)
RGD
PMID:21167192
RGD:5509890
NCBI chrNW_004955467:10,109,985...10,118,687
Ensembl chrNW_004955467:10,110,003...10,123,022
G
Atp7a
ATPase copper transporting alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23792645
NCBI chrNW_004955557:1,355,471...1,515,725
Ensembl chrNW_004955557:1,355,397...1,515,393
G
Atp7b
ATPase copper transporting beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23792645
NCBI chrNW_004955431:5,228,395...5,297,120
Ensembl chrNW_004955431:5,229,126...5,269,616
G
Bak1
BCL2 antagonist/killer 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chrNW_004955437:2,036,415...2,041,997
Ensembl chrNW_004955437:2,036,415...2,041,997
G
Bbc3
BCL2 binding component 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chrNW_004955574:1,167,790...1,174,966
Ensembl chrNW_004955574:1,167,242...1,174,966
G
Bcl2
BCL2 apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10426811 PMID:28100771
NCBI chrNW_004955402:46,911,125...47,084,214
Ensembl chrNW_004955402:46,916,266...47,084,485
G
Bcl2l1
BCL2 like 1
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:10426811 PMID:22414765 PMID:28100771
RGD:11353865
NCBI chrNW_004955422:29,254,440...29,307,104
Ensembl chrNW_004955422:29,254,216...29,308,174
G
Ca3
carbonic anhydrase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chrNW_004955417:3,362,091...3,372,270
Ensembl chrNW_004955417:3,362,492...3,372,932
G
Cad
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
ISO
protein:increased activity:liver (rat)
RGD
PMID:13618893
RGD:5132586
NCBI chrNW_004955469:9,203,433...9,227,526
Ensembl chrNW_004955469:9,203,434...9,227,865
G
Ccl20
C-C motif chemokine ligand 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30603057
NCBI chrNW_004955453:6,846,625...6,850,007
Ensembl chrNW_004955453:6,846,549...6,850,031
G
Ccnb1
cyclin B1
ISO
mRNA:increased expression:liver
RGD
PMID:17342310
RGD:2315991
NCBI chrNW_004955446:140,661...149,500
Ensembl chrNW_004955446:140,093...149,500
G
Ccnd1
cyclin D1
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17055752 PMID:28100771
RGD:2289139
NCBI chrNW_004955422:16,449,921...16,462,676
Ensembl chrNW_004955422:16,448,770...16,463,300
G
Ccndbp1
cyclin D1 binding protein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16501603
NCBI chrNW_004955416:9,772,823...9,782,047
Ensembl chrNW_004955416:9,772,823...9,782,047
G
Ccng1
cyclin G1
ISO
RGD
PMID:27982046
RGD:151361200
NCBI chrNW_004955408:16,846,050...16,850,365
G
Ccng2
cyclin G2
ISO
RGD
PMID:27982046
RGD:151361200
NCBI chrNW_004955433:1,799,405...1,807,050
Ensembl chrNW_004955433:1,798,732...1,807,827
G
Cd40lg
CD40 ligand
ISO
RGD
PMID:19035311
RGD:5491179
NCBI chrNW_004955489:8,465,571...8,477,714
Ensembl chrNW_004955489:8,465,164...8,477,746
G
Cd63
CD63 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chrNW_004955458:3,362,511...3,363,916
Ensembl chrNW_004955458:3,362,511...3,363,981
G
Cdh1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20118494 PMID:25319454
NCBI chrNW_004955484:7,782,409...7,861,082
Ensembl chrNW_004955484:7,782,772...7,860,967
G
Cdkn1a
cyclin dependent kinase inhibitor 1A
ISO
protein:decreased expression:liver:
RGD
PMID:8640740
RGD:8662309
NCBI chrNW_004955437:6,254,638...6,261,278
Ensembl chrNW_004955437:6,254,309...6,261,479
G
Cdkn1b
cyclin dependent kinase inhibitor 1B
disease_progression
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:19533683
RGD:2315050
NCBI chrNW_004955413:9,615,542...9,620,542
Ensembl chrNW_004955413:9,615,542...9,620,542
G
Cdkn1c
cyclin dependent kinase inhibitor 1C
disease_progression
ISO
protein:decreased expression:liver (rat) protein:increased expression:liver (rat) mRNA:increased expression:liver (rat)
RGD
PMID:3965145 PMID:19533683 PMID:26606000
RGD:11354707 RGD:152998958 RGD:2315050
NCBI chrNW_004955422:14,576,971...14,578,868
G
Cops5
COP9 signalosome subunit 5
ISO
protein:increased expression:liver (rat)
RGD
PMID:26606000
RGD:11354707
NCBI chrNW_004955444:12,217,337...12,233,570
Ensembl chrNW_004955444:12,217,337...12,234,193
G
Cp
ceruloplasmin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23792645
NCBI chrNW_004955448:470,063...522,909
Ensembl chrNW_004955448:473,179...523,100
G
Cps1
carbamoyl-phosphate synthase 1
severity
ISO
mRNA:decreased expression:liver
RGD
PMID:3387993
RGD:2303406
NCBI chrNW_004955457:4,848,116...4,961,384
Ensembl chrNW_004955457:4,844,152...4,961,246
G
Ctnnb1
catenin beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11280770 PMID:20118494 PMID:21147764
NCBI chrNW_004955420:29,030,716...29,047,447
Ensembl chrNW_004955420:29,030,716...29,047,449
G
Cxcl9
C-X-C motif chemokine ligand 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chrNW_004955433:724,566...731,945
Ensembl chrNW_004955433:724,515...732,192
G
Dhodh
dihydroorotate dehydrogenase (quinone)
ISO
protein:increased activity:liver (rat)
RGD
PMID:6331524
RGD:5132618
NCBI chrNW_004955484:4,699,743...4,713,466
Ensembl chrNW_004955484:4,699,722...4,713,466
G
Dtymk
deoxythymidylate kinase
ISO
protein:increased activity:tumor (rat)
RGD
PMID:6244089
RGD:5133686
NCBI chrNW_004955542:155,741...163,759
Ensembl chrNW_004955542:155,742...163,759
G
Eno2
enolase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2910524
NCBI chrNW_004955413:4,498,625...4,506,769
Ensembl chrNW_004955413:4,498,625...4,506,769
G
Ephx1
epoxide hydrolase 1
ISO
RGD
PMID:7260898
RGD:11252158
NCBI chrNW_004955520:116,363...142,983
Ensembl chrNW_004955520:116,363...128,665
G
F12
coagulation factor XII
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chrNW_004955408:29,644,279...29,665,161
Ensembl chrNW_004955408:29,642,096...29,650,950
G
Fas
Fas cell surface death receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30737368
NCBI chrNW_004955425:3,961,671...3,987,513
Ensembl chrNW_004955425:3,961,013...3,987,455
G
Foxm1
forkhead box M1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15082532
NCBI chrNW_004955429:18,392,545...18,405,254
Ensembl chrNW_004955429:18,393,470...18,405,254
G
Gjb1
gap junction protein beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:1336494 PMID:18308698
RGD:7349398
NCBI chrNW_004955475:10,779,415...10,787,910
Ensembl chrNW_004955475:10,785,996...10,787,910
G
Gjb2
gap junction protein beta 2
ISO
RGD
PMID:1336494
RGD:7349398
NCBI chrNW_004955497:987,213...989,477
Ensembl chrNW_004955497:988,422...989,099
G
Glul
glutamate-ammonia ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20118494 PMID:21147764
NCBI chrNW_004955406:21,266,383...21,274,546
Ensembl chrNW_004955406:21,266,383...21,275,309
G
Grp
gastrin releasing peptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2910524
NCBI chrNW_004955402:43,382,608...43,393,452
Ensembl chrNW_004955402:43,382,552...43,393,463
G
Gstp1
glutathione S-transferase pi 1
ISO
protein:increased expression:liver (rat) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:2563599 PMID:3124819 PMID:3965145 PMID:7585603 PMID:12016164 PMID:20188851 More...
RGD:152998958 RGD:2317823
NCBI chrNW_004955422:17,914,228...17,916,918
Ensembl chrNW_004955422:17,914,305...17,917,428
G
Hat1
histone acetyltransferase 1
ISO
protein:increased expression:liver
RGD
PMID:17182829
RGD:2316578
NCBI chrNW_004955449:3,026,194...3,070,448
Ensembl chrNW_004955449:3,025,461...3,066,919
G
Hgf
hepatocyte growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11896611
NCBI chrNW_004955410:4,114,280...4,181,953
Ensembl chrNW_004955410:4,114,778...4,182,058
G
Hras
HRas proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7955063 PMID:20118494 PMID:21147764 PMID:27517622
NCBI chrNW_004955476:11,508,446...11,510,333
Ensembl chrNW_004955476:11,508,126...11,510,333
G
Htr2c
5-hydroxytryptamine receptor 2C
ISO
protein:increased expression:brainstem, cerebral cortex
RGD
PMID:17258772
RGD:1624998
NCBI chrNW_004955490:912,615...1,126,347
Ensembl chrNW_004955490:910,415...1,126,373
G
Igf2
insulin like growth factor 2
treatment
ISO
RGD
PMID:22425635
RGD:10402567
NCBI chrNW_004955422:13,880,525...13,907,963
Ensembl chrNW_004955422:13,880,471...13,888,566
G
Igf2r
insulin like growth factor 2 receptor
ISO
RGD
PMID:9652747 PMID:15057872
RGD:2311623 RGD:2311630
NCBI chrNW_004955439:20,754,915...20,874,759
Ensembl chrNW_004955439:20,752,855...20,851,281
G
Ikbkg
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30737368
NCBI chrNW_004955580:1,053,823...1,069,802
Ensembl chrNW_004955580:1,053,823...1,069,802
G
Il6
interleukin 6
disease_progression
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:blood serum (mouse)
CTD RGD
PMID:26297436 PMID:26569409
RGD:11344640
NCBI chrNW_004955410:25,079,835...25,084,390
G
Insr
insulin receptor
disease_progression
ISO
associated with Diabetes Mellitus, Experimental;protein:increased expression:cytoplasm,liver (rat)
RGD
PMID:15520221
RGD:2306052
NCBI chrNW_004955563:1,867,400...2,011,845
Ensembl chrNW_004955563:1,867,400...2,009,149
G
Jak2
Janus kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chrNW_004955434:9,227,897...9,341,208
Ensembl chrNW_004955434:9,227,595...9,341,208
G
Kat6a
lysine acetyltransferase 6A
ISO
protein:increased expression:liver (rat)
RGD
PMID:17083329
RGD:2312274
NCBI chrNW_004955536:900,198...1,015,520
Ensembl chrNW_004955536:900,198...1,015,520
G
Kdr
kinase insert domain receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11956651
NCBI chrNW_004955447:15,810,816...15,851,702
Ensembl chrNW_004955447:15,810,815...15,853,583
G
Kras
KRAS proto-oncogene, GTPase
disease_progression
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (rat)
CTD RGD
PMID:8603461 PMID:19533683
RGD:2315050
NCBI chrNW_004955413:20,298,852...20,328,756
Ensembl chrNW_004955413:20,298,824...20,328,758
G
LOC102004212
cytochrome P450 2F3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chrNW_004955578:530,094...541,951
Ensembl chrNW_004955578:531,353...541,684
G
LOC102010322
cytochrome P450 1A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11376689 PMID:21147764
NCBI chrNW_004955450:3,165,107...3,171,894
Ensembl chrNW_004955450:3,165,106...3,171,942
G
LOC102010850
cytochrome P450 1A1
ISO
mRNA:increased expression:liver
RGD
PMID:22687991
RGD:7296954
NCBI chrNW_004955450:3,183,958...3,189,488
Ensembl chrNW_004955450:3,183,750...3,189,488
G
LOC102021597
alpha-1-antiproteinase S-like
ISO
RGD
PMID:10569800
RGD:1626391
NCBI chrNW_004955438:17,920,200...17,929,105
G
LOC102026028
cytochrome P450 2E1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18056438
NCBI chrNW_004955507:6,293,162...6,303,255
Ensembl chrNW_004955507:6,289,576...6,304,193
G
Map2k1
mitogen-activated protein kinase kinase 1
ISO
associated with Diabetes Mellitus, Experimental;protein:increased expression:liver
RGD
PMID:15520221
RGD:2306052
NCBI chrNW_004955450:9,181,851...9,205,277
Ensembl chrNW_004955450:9,181,851...9,239,648
G
Mapk1
mitogen-activated protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chrNW_004955442:17,284,232...17,380,026
Ensembl chrNW_004955442:17,284,232...17,380,020
G
Mapk3
mitogen-activated protein kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chrNW_004955493:6,870,699...6,876,836
Ensembl chrNW_004955493:6,869,668...6,879,152
G
Met
MET proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11956651
NCBI chrNW_004955432:22,440,671...22,519,592
Ensembl chrNW_004955432:22,440,637...22,517,647
G
Mfge8
milk fat globule EGF and factor V/VIII domain containing
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chrNW_004955416:16,092,263...16,103,097
Ensembl chrNW_004955416:16,091,684...16,103,768
G
Mmp2
matrix metallopeptidase 2
ISO
mRNA, protein:increased expression, increased activity:liver CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19528495 PMID:19539802 PMID:30603057
RGD:2325734 RGD:2325736
NCBI chrNW_004955433:13,024,844...13,050,041
Ensembl chrNW_004955433:13,024,418...13,052,775
G
Mmp9
matrix metallopeptidase 9
ISO
mRNA, protein:increased expression, increased activity:liver
RGD
PMID:19528495 PMID:19539802
RGD:2325734 RGD:2325736
NCBI chrNW_004955445:11,295,500...11,303,322
Ensembl chrNW_004955445:11,295,448...11,303,288
G
Mpeg1
macrophage expressed 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chrNW_004955511:3,783,200...3,787,300
Ensembl chrNW_004955511:3,785,019...3,787,154
G
Myc
MYC proto-oncogene, bHLH transcription factor
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (rat)
CTD RGD
PMID:3335218 PMID:9079223 PMID:11280770 PMID:18560566
RGD:10059623
NCBI chrNW_004955461:2,714,022...2,718,872
Ensembl chrNW_004955461:2,714,022...2,718,982
G
Nos2
nitric oxide synthase 2
ISO
protein:increased expression:liver
RGD
PMID:10383909
RGD:2325277
NCBI chrNW_004955481:5,197,957...5,232,406
Ensembl chrNW_004955481:5,201,234...5,231,961
G
Notch1
notch receptor 1
ISO
protein:increased expression:liver
RGD
PMID:18942116
RGD:2325310
NCBI chrNW_004955513:4,225,939...4,264,875
Ensembl chrNW_004955513:4,225,956...4,263,259
G
Nqo1
NAD(P)H quinone dehydrogenase 1
ISO
mRNA, protein:increased expression:liver (rat)
RGD
PMID:27867096
RGD:13442478
NCBI chrNW_004955484:7,012,373...7,028,182
Ensembl chrNW_004955484:7,012,506...7,027,604
G
Nr1h4
nuclear receptor subfamily 1 group H member 4
susceptibility
ISO
RGD
PMID:17283114
RGD:14701032
NCBI chrNW_004955405:36,160,360...36,236,258
Ensembl chrNW_004955405:36,160,049...36,237,751
G
Nr1i3
nuclear receptor subfamily 1 group I member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17172636 PMID:24769335 PMID:25656644
NCBI chrNW_004955468:12,985,105...13,002,850
G
Nras
NRAS proto-oncogene, GTPase
ISO
human gene in mouse model
RGD
PMID:16286660
RGD:14975105
NCBI chrNW_004955435:18,001,517...18,009,105
Ensembl chrNW_004955435:18,001,517...18,009,103
G
Pemt
phosphatidylethanolamine N-methyltransferase
ISO
protein:decreased expression:liver
RGD
PMID:7929120
RGD:1642378
NCBI chrNW_004955577:365,031...443,138
Ensembl chrNW_004955577:367,288...443,138
G
Plcl1
phospholipase C like 1 (inactive)
disease_progression
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:19533683
RGD:2315050
NCBI chrNW_004955403:2,643,092...2,904,651
Ensembl chrNW_004955403:2,641,360...2,693,352
G
Pml
PML nuclear body scaffold
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20377131
NCBI chrNW_004955450:3,654,854...3,692,057
Ensembl chrNW_004955450:3,656,498...3,692,406
G
Ppat
phosphoribosyl pyrophosphate amidotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:761203
NCBI chrNW_004955447:14,552,846...14,607,416
Ensembl chrNW_004955447:14,574,407...14,607,416
G
Ppp2ca
protein phosphatase 2 catalytic subunit alpha
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:2562181
RGD:8693574
NCBI chrNW_004955408:5,435,117...5,460,361
Ensembl chrNW_004955408:5,433,268...5,460,361
G
Prdx1
peroxiredoxin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27517622
NCBI chrNW_004955464:12,761,390...12,773,413
Ensembl chrNW_004955464:12,761,401...12,773,146
G
Ptgr1
prostaglandin reductase 1
ISO
protein:increased expression:liver
RGD
PMID:24853774
RGD:14401713
NCBI chrNW_004955419:15,708,456...15,738,774
Ensembl chrNW_004955419:15,708,456...15,739,147
G
Rad51
RAD51 recombinase
ISO
protein:decreased expression:liver
RGD
PMID:17219426
RGD:2292638
NCBI chrNW_004955416:7,566,715...7,590,628
Ensembl chrNW_004955416:7,566,686...7,590,628
G
Rb1
RB transcriptional corepressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17854601
NCBI chrNW_004955431:1,960,765...2,124,576
Ensembl chrNW_004955431:1,960,661...2,124,576
G
Rgn
regucalcin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chrNW_004955516:958,416...978,829
Ensembl chrNW_004955516:955,680...978,910
G
Rida
reactive intermediate imine deaminase A homolog
ISO
protein:increased expression:liver (rat)
RGD
PMID:12939504
RGD:9685719
NCBI chrNW_004955417:13,810,596...13,822,982
Ensembl chrNW_004955417:13,810,596...13,822,982
G
Rras2
RAS related 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147764
NCBI chrNW_004955414:29,482,502...29,546,102
Ensembl chrNW_004955414:29,481,343...29,493,070
G
Rrm1
ribonucleotide reductase catalytic subunit M1
ISO
RGD
PMID:15224347
RGD:2316863
NCBI chrNW_004955414:19,850,523...19,904,879
Ensembl chrNW_004955414:19,850,530...19,905,266
G
Rxra
retinoid X receptor alpha
ISO
mRNA, protein:decreased expression:liver
RGD
PMID:17786350
RGD:1643105
NCBI chrNW_004955513:3,313,544...3,386,544
Ensembl chrNW_004955513:3,335,897...3,386,994
G
Slc31a1
solute carrier family 31 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23792645
NCBI chrNW_004955419:14,221,258...14,264,288
Ensembl chrNW_004955419:14,220,495...14,264,699
G
Slc7a5
solute carrier family 7 member 5
ISO
mRNA:increased expression:liver
RGD
PMID:17498859
RGD:151357003
NCBI chrNW_004955541:2,103,437...2,129,668
Ensembl chrNW_004955541:2,103,384...2,130,310
G
Socs1
suppressor of cytokine signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15197228
NCBI chrNW_004955442:7,321,337...7,323,109
Ensembl chrNW_004955442:7,321,337...7,323,109
G
Sox4
SRY-box transcription factor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147764
NCBI chrNW_004955483:5,076,664...5,077,059
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chrNW_004955474:1,914,477...1,922,025
Ensembl chrNW_004955474:1,913,829...1,922,016
G
Sqle
squalene epoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chrNW_004955461:121,886...143,389
Ensembl chrNW_004955461:122,528...143,064
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26297436 PMID:28100771
NCBI chrNW_004955451:16,320,326...16,348,505
Ensembl chrNW_004955451:16,319,904...16,357,687
G
Tek
TEK receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11956651
NCBI chrNW_004955472:7,633,790...7,748,130
Ensembl chrNW_004955472:7,633,721...7,748,386
G
Tgfa
transforming growth factor alpha
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver
CTD RGD
PMID:9079223 PMID:16734725
RGD:2317490
NCBI chrNW_004955424:14,616,390...14,709,723
Ensembl chrNW_004955424:14,616,259...14,710,183
G
Tgfb1
transforming growth factor beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chrNW_004955555:274,405...288,441
Ensembl chrNW_004955555:270,652...288,441
G
Tk1
thymidine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chrNW_004955506:4,379,830...4,390,729
Ensembl chrNW_004955506:4,379,830...4,394,713
G
Tnf
tumor necrosis factor
treatment disease_progression
ISO
Morris hepatoma protein:increased expression:blood serum (mouse) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:9063767 PMID:26569409 PMID:28100771
RGD:11344640 RGD:14696818
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
G
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10626228 PMID:28100771
NCBI chrNW_004955467:9,241,391...9,256,716
Ensembl chrNW_004955467:9,252,130...9,255,928
G
Tsc22d1
TSC22 domain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15833021 PMID:17533171
NCBI chrNW_004955518:2,322,566...2,451,519
Ensembl chrNW_004955518:2,321,226...2,450,812
G
Vim
vimentin
ISO
RGD
PMID:19199359
RGD:6480440
NCBI chrNW_004955429:10,708,852...10,716,743
Ensembl chrNW_004955429:10,707,719...10,717,554
G
Acss1
acyl-CoA synthetase short chain family member 1
treatment
ISO
RGD
PMID:27539851
RGD:13831304
NCBI chrNW_004955415:31,117,542...31,154,654
Ensembl chrNW_004955415:31,117,303...31,154,654
G
Acss2
acyl-CoA synthetase short chain family member 2
treatment
ISO
RGD
PMID:27539851
RGD:13831304
NCBI chrNW_004955422:26,450,899...26,500,336
Ensembl chrNW_004955422:26,451,598...26,500,546
G
Antxr1
ANTXR cell adhesion molecule 1
treatment
ISO
RGD
PMID:19609240 PMID:19622764
RGD:9684925 RGD:9684939
NCBI chrNW_004955424:15,820,734...16,034,278
Ensembl chrNW_004955424:15,824,435...16,033,946
G
Braf
B-Raf proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29179997 PMID:29438700
NCBI chrNW_004955494:2,567,238...2,712,708
G
Calr
calreticulin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16388313
NCBI chrNW_004955415:31,985,147...31,989,372
Ensembl chrNW_004955415:31,985,147...31,989,372
G
Ccl20
C-C motif chemokine ligand 20
treatment
ISO
RGD
PMID:14500387
RGD:7483600
NCBI chrNW_004955453:6,846,625...6,850,007
Ensembl chrNW_004955453:6,846,549...6,850,031
G
Ctla4
cytotoxic T-lymphocyte associated protein 4
treatment
ISO
RGD
PMID:24041689
RGD:7411680
NCBI chrNW_004955457:11,028,707...11,034,898
Ensembl chrNW_004955457:11,028,698...11,073,460
G
Egr1
early growth response 1
ISO
mRNA, protein:increased expression:salivary gland (mouse)
RGD
PMID:19517020
RGD:5131885
NCBI chrNW_004955418:2,001,509...2,005,269
Ensembl chrNW_004955418:2,002,699...2,005,007
G
Esr2
estrogen receptor 2
severity
ISO
RGD
PMID:20354658
RGD:8694122
NCBI chrNW_004955466:5,587,003...5,644,765
Ensembl chrNW_004955466:5,575,088...5,638,946
G
Hgf
hepatocyte growth factor
ISO
RGD
PMID:9823327
RGD:8548620
NCBI chrNW_004955410:4,114,280...4,181,953
Ensembl chrNW_004955410:4,114,778...4,182,058
G
Ifnb1
interferon beta 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16417267
NCBI chrNW_004955434:23,301,623...23,302,304
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
ISO
RGD
PMID:19276165
RGD:7495758
NCBI chrNW_004955536:611,965...658,647
Ensembl chrNW_004955536:612,774...658,647
G
Il18
interleukin 18
treatment
ISO
RGD
PMID:12230493 PMID:17411412
RGD:8655870 RGD:8655901
NCBI chrNW_004955412:13,807,361...13,826,007
Ensembl chrNW_004955412:13,806,553...13,825,634
G
Il1a
interleukin 1 alpha
treatment
ISO
RGD
PMID:8061895
RGD:7794735
NCBI chrNW_004955470:1,527,710...1,538,418
Ensembl chrNW_004955470:1,527,674...1,538,466
G
Il1b
interleukin 1 beta
ISO
RGD
PMID:1966551
RGD:7401226
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
G
Il2
interleukin 2
ISO
RGD
PMID:11884028
RGD:8662950
NCBI chrNW_004955428:18,163,010...18,168,157
Ensembl chrNW_004955428:18,162,467...18,168,265
G
Kdm1a
lysine demethylase 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29438700
NCBI chrNW_004955452:3,044,042...3,104,650
Ensembl chrNW_004955452:3,044,264...3,104,418
G
Kdm4c
lysine demethylase 4C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29438700
NCBI chrNW_004955434:10,646,524...11,000,589
Ensembl chrNW_004955434:10,685,704...11,000,644
G
Pdcd1
programmed cell death 1
treatment
ISO
RGD
PMID:19208793
RGD:9589070
NCBI chrNW_004955542:49,290...57,747
Ensembl chrNW_004955542:49,259...58,823
G
Pten
phosphatase and tensin homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29179997
NCBI chrNW_004955425:5,007,811...5,091,829
Ensembl chrNW_004955425:5,014,147...5,091,829
G
Pxn
paxillin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18492274
NCBI chrNW_004955455:11,387,140...11,401,178
Ensembl chrNW_004955455:11,388,378...11,403,082
G
Tert
telomerase reverse transcriptase
treatment
ISO
RGD
PMID:19903903
RGD:11038656
NCBI chrNW_004955504:649,248...669,796
Ensembl chrNW_004955504:651,779...670,589
G
Agps
alkylglycerone phosphate synthase
ISO
RGD
PMID:7407223
RGD:1598794
NCBI chrNW_004955403:19,253,784...19,381,883
Ensembl chrNW_004955403:19,257,501...19,381,901
G
Alb
albumin
ISO
mRNA,protein:decreased expression:liver,serum:
RGD
PMID:1900492
RGD:11035284
NCBI chrNW_004955447:9,327...21,212
G
Epo
erythropoietin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9743294
NCBI chrNW_004955573:203,875...206,078
Ensembl chrNW_004955573:203,441...206,355
G
Ifng
interferon gamma
treatment
ISO
RGD
PMID:2119881
RGD:10755752
NCBI chrNW_004955458:14,643,333...14,648,020
Ensembl chrNW_004955458:14,643,313...14,648,045
G
Kras
KRAS proto-oncogene, GTPase
ISO
A to T transversion; Gln to His substitution
RGD
PMID:11295286
RGD:1598680
NCBI chrNW_004955413:20,298,852...20,328,756
Ensembl chrNW_004955413:20,298,824...20,328,758
G
Nras
NRAS proto-oncogene, GTPase
ISO
DNA:transversion:exon p.Q61L (human)
RGD
PMID:11295286
RGD:1598680
NCBI chrNW_004955435:18,001,517...18,009,105
Ensembl chrNW_004955435:18,001,517...18,009,103
G
Slc6a14
solute carrier family 6 member 14
ISO
mRNA, protein:increased expression:brush border epithelial cell
RGD
PMID:17006743
RGD:1625275
NCBI chrNW_004955534:3,463,057...3,488,577
G
Abcb1
ATP binding cassette subfamily B member 1
ISO
RGD
PMID:19654309
RGD:2315553
NCBI chrNW_004955432:4,911,774...5,085,349
G
Abcg2
ATP binding cassette subfamily G member 2 (Junior blood group)
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22767648
NCBI chrNW_004955474:12,365,903...12,408,715
G
Acsl1
acyl-CoA synthetase long chain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955403:24,190,674...24,235,354
Ensembl chrNW_004955403:24,190,674...24,236,780
G
Actb
actin beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955460:10,358,100...10,361,585
Ensembl chrNW_004955460:10,356,699...10,361,585
G
Actg1
actin gamma 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955506:1,546,678...1,549,611
Ensembl chrNW_004955506:1,546,678...1,552,105
G
Actn4
actinin alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955468:770,573...841,859
Ensembl chrNW_004955468:770,573...842,209
G
Adipoq
adiponectin, C1Q and collagen domain containing
treatment disease_progression
ISO
RGD
PMID:19447866 PMID:22246620
RGD:8694414 RGD:8694468
NCBI chrNW_004955420:20,911,181...20,922,992
Ensembl chrNW_004955420:20,912,348...20,914,402
G
Agt
angiotensinogen
treatment
ISO
RGD
PMID:20837666
RGD:5129167
NCBI chrNW_004955492:7,863,662...7,874,863
Ensembl chrNW_004955492:7,866,833...7,873,357
G
Agtr1
angiotensin II receptor type 1
ISO
RGD
PMID:18421211
RGD:2292665
NCBI chrNW_004955474:8,733,942...8,781,305
Ensembl chrNW_004955474:8,733,942...8,781,255
G
Agtr2
angiotensin II receptor type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8389152
NCBI chrNW_004955534:3,653,112...3,654,248
Ensembl chrNW_004955534:3,653,157...3,654,248
G
Akt1
AKT serine/threonine kinase 1
ISO
RGD
PMID:17210696
RGD:2315600
NCBI chrNW_004955538:3,208,711...3,224,386
Ensembl chrNW_004955538:3,208,710...3,229,904
G
Akt2
AKT serine/threonine kinase 2
ISO
RGD
PMID:17210696
RGD:2315600
NCBI chrNW_004955578:950,258...1,004,438
Ensembl chrNW_004955578:967,593...1,004,438
G
Alcam
activated leukocyte cell adhesion molecule
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:16316942
RGD:2306898
NCBI chrNW_004955427:6,494,657...6,544,668
Ensembl chrNW_004955427:6,494,124...6,545,963
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
ISO
mRNA:increased expression:mammary gland tumor (rat)
RGD
PMID:18959458
RGD:2313895
NCBI chrNW_004955431:15,071,535...15,097,496
Ensembl chrNW_004955431:15,069,089...15,097,580
G
Antxr1
ANTXR cell adhesion molecule 1
disease_progression
ISO
RGD
PMID:22085271
RGD:9684855
NCBI chrNW_004955424:15,820,734...16,034,278
Ensembl chrNW_004955424:15,824,435...16,033,946
G
Anxa1
annexin A1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12376462 PMID:16316942
RGD:2306898
NCBI chrNW_004955512:5,686,508...5,703,645
G
Anxa4
annexin A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955424:15,323,604...15,389,136
Ensembl chrNW_004955424:15,321,990...15,389,136
G
Apaf1
apoptotic peptidase activating factor 1
ISO
RGD
PMID:14973070
RGD:2325748
NCBI chrNW_004955405:34,619,780...34,693,616
Ensembl chrNW_004955405:34,623,267...34,693,677
G
Apoe
apolipoprotein E
ISO
RGD
PMID:22469977
RGD:7771597
NCBI chrNW_004955555:1,998,170...2,002,003
Ensembl chrNW_004955555:1,999,711...2,001,888
G
Aqp1
aquaporin 1 (Colton blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955410:32,066,196...32,078,661
Ensembl chrNW_004955410:32,066,196...32,078,717
G
Ar
androgen receptor
ISO
RGD
PMID:12150826
RGD:6482679
NCBI chrNW_004955475:7,013,960...7,192,473
Ensembl chrNW_004955475:7,013,960...7,186,069
G
Areg
amphiregulin
ISO
mRNA:increased expression:mammary gland protein:increased expression:mammary gland
RGD
PMID:10225449 PMID:18421211
RGD:2292663 RGD:2292665
NCBI chrNW_004955474:680,212...689,021
Ensembl chrNW_004955474:680,204...689,088
G
Arhgap5
Rho GTPase activating protein 5
disease_progression
ISO
mRNA:increased expression:mammary gland
RGD
PMID:10939588 PMID:19703301
RGD:126848766 RGD:2316183
NCBI chrNW_004955409:28,627,176...28,682,302
Ensembl chrNW_004955409:28,627,176...28,705,893
G
Atp5if1
ATP synthase inhibitory factor subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chrNW_004955452:7,372,917...7,375,072
Ensembl chrNW_004955452:7,373,001...7,375,856
G
Aurka
aurora kinase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12124350
NCBI chrNW_004955445:2,831,073...2,853,151
Ensembl chrNW_004955445:2,831,157...2,853,357
G
Bad
BCL2 associated agonist of cell death
treatment severity
ISO
RGD
PMID:20732338 PMID:23404339
RGD:10053670 RGD:10053708
NCBI chrNW_004955422:20,795,585...20,809,039
Ensembl chrNW_004955422:20,795,676...20,809,245
G
Bak1
BCL2 antagonist/killer 1
ISO
RGD
PMID:19222350
RGD:2315700
NCBI chrNW_004955437:2,036,415...2,041,997
Ensembl chrNW_004955437:2,036,415...2,041,997
G
Bard1
BRCA1 associated RING domain 1
ISO
RGD
PMID:18443292
RGD:2293149
NCBI chrNW_004955457:1,187,942...1,258,475
Ensembl chrNW_004955457:1,187,942...1,253,803
G
Basp1
brain abundant membrane attached signal protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955426:6,149,756...6,193,222
Ensembl chrNW_004955426:6,149,756...6,193,209
G
Bax
BCL2 associated X, apoptosis regulator
severity treatment
ISO
RGD
PMID:20732338 PMID:23404339
RGD:10053670 RGD:10053708
NCBI chrNW_004955559:1,695,960...1,700,246
Ensembl chrNW_004955559:1,695,960...1,700,244
G
Bcl2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:22668016 PMID:23404339
RGD:10053670 RGD:10054128
NCBI chrNW_004955402:46,911,125...47,084,214
Ensembl chrNW_004955402:46,916,266...47,084,485
G
Bcl2l1
BCL2 like 1
treatment
ISO
RGD
PMID:23404339
RGD:10053670
NCBI chrNW_004955422:29,254,440...29,307,104
Ensembl chrNW_004955422:29,254,216...29,308,174
G
Brca1
BRCA1 DNA repair associated
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12203372 PMID:17505536 PMID:18443292 PMID:22767648
RGD:1599502 RGD:2293149 RGD:2293155
NCBI chrNW_004955451:16,819,463...16,870,780
Ensembl chrNW_004955451:16,819,023...16,855,528
G
Ca9
carbonic anhydrase 9
ISO
RGD
PMID:17280655
RGD:2293194
NCBI chrNW_004955472:619,084...625,570
Ensembl chrNW_004955472:619,245...625,051
G
Cad
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
disease_progression
ISO
protein:increased expression:mammary gland
RGD
PMID:6030068
RGD:2303540
NCBI chrNW_004955469:9,203,433...9,227,526
Ensembl chrNW_004955469:9,203,434...9,227,865
G
Capzb
capping actin protein of muscle Z-line subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955452:34,454...168,514
Ensembl chrNW_004955452:30,589...169,693
G
Cask
calcium/calmodulin dependent serine protein kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955565:879,560...1,242,727
Ensembl chrNW_004955565:879,830...1,237,692
G
Casp3
caspase 3
treatment severity
ISO
RGD
PMID:20732338 PMID:23404339 PMID:26699876
RGD:10053670 RGD:10053708 RGD:13782283
NCBI chrNW_004955403:24,315,712...24,326,271
G
Casp7
caspase 7
treatment
ISO
RGD
PMID:23404339 PMID:23979166 PMID:26699876
RGD:10053670 RGD:13209143 RGD:13782283
NCBI chrNW_004955431:18,685,408...18,723,221
Ensembl chrNW_004955431:18,686,190...18,723,524
G
Casp8
caspase 8
severity
ISO
RGD
PMID:20732338
RGD:10053708
NCBI chrNW_004955403:322,082...348,591
Ensembl chrNW_004955403:322,555...347,053
G
Casp9
caspase 9
treatment severity
ISO
RGD
PMID:17297389 PMID:20012353 PMID:20732338 PMID:26699876
RGD:10053708 RGD:13782283 RGD:2315928 RGD:2315933
NCBI chrNW_004955527:2,613,691...2,630,217
Ensembl chrNW_004955527:2,613,683...2,629,738
G
Cav1
caveolin 1
onset treatment
ISO
protein:decreased expression:mammary gland
RGD
PMID:9685399 PMID:15334058 PMID:15355971
RGD:2289100 RGD:2289106 RGD:8661780
NCBI chrNW_004955432:22,258,262...22,292,403
Ensembl chrNW_004955432:22,258,250...22,292,403
G
Ccna2
cyclin A2
ISO
protein:increased expression:mammary gland
RGD
PMID:10713672
RGD:2293347
NCBI chrNW_004955428:18,725,969...18,732,478
Ensembl chrNW_004955428:18,726,062...18,732,211
G
Ccnb1
cyclin B1
ISO
RGD
PMID:11146550
RGD:2315939
NCBI chrNW_004955446:140,661...149,500
Ensembl chrNW_004955446:140,093...149,500
G
Ccnd1
cyclin D1
ISO
mRNA, protein:increased expression:mammary gland (rat) mRNA:increased expression:mammary gland (rat) CTD Direct Evidence: marker/mechanism protein:decreased expression:mammary gland
RGD CTD
PMID:12376462 PMID:12602925 PMID:12649181 PMID:14522882 PMID:16316942 PMID:17440082 More...
RGD:2289336 RGD:2289337 RGD:2292404 RGD:2296037 RGD:2306898
NCBI chrNW_004955422:16,449,921...16,462,676
Ensembl chrNW_004955422:16,448,770...16,463,300
G
Ccnd3
cyclin D3
ISO
mRNA, protein:increased expression:mammary gland
RGD
PMID:12853979 PMID:16311245
RGD:2316015 RGD:2316020
NCBI chrNW_004955437:8,266,523...8,273,855
Ensembl chrNW_004955437:8,268,118...8,273,855
G
Ccne1
cyclin E1
ISO
protein:decreased expression:mammary gland
RGD
PMID:12602925 PMID:12649181
RGD:2289336 RGD:2289337
NCBI chrNW_004955468:7,803,610...7,814,872
Ensembl chrNW_004955468:7,803,346...7,814,872
G
Ccnh
cyclin H
ISO
mRNA:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12606953
RGD:9590264
NCBI chrNW_004955418:23,790,398...23,807,509
Ensembl chrNW_004955418:23,790,001...23,807,702
G
Ccr3
C-C motif chemokine receptor 3
ISO
RGD
PMID:21621198
RGD:6893427
NCBI chrNW_004955420:25,702,917...25,723,269
Ensembl chrNW_004955420:25,701,407...25,723,353
G
Cd274
CD274 molecule
treatment
ISO
RGD
PMID:29043842
RGD:40886270
NCBI chrNW_004955434:9,487,309...9,508,366
Ensembl chrNW_004955434:9,487,315...9,505,904
G
Cd40
CD40 molecule
ISO
RGD
PMID:21137078
RGD:8547744
NCBI chrNW_004955445:11,191,817...11,202,156
Ensembl chrNW_004955445:11,190,603...11,202,093
G
Cd44
CD44 molecule (Indian blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chrNW_004955422:11,106,061...11,189,951
G
Cdc25a
cell division cycle 25A
ISO
RGD
PMID:16951165 PMID:17283130 PMID:17638870
RGD:2754551 RGD:2764000 RGD:2771824
NCBI chrNW_004955420:24,345,002...24,361,802
Ensembl chrNW_004955420:24,344,388...24,362,596
G
Cdc42
cell division cycle 42
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955452:2,255,940...2,299,042
Ensembl chrNW_004955452:2,255,117...2,299,042
G
Cdh1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955484:7,782,409...7,861,082
Ensembl chrNW_004955484:7,782,772...7,860,967
G
Cdh13
cadherin 13
severity
ISO
RGD
PMID:18316604
RGD:2293540
NCBI chrNW_004955564:407,120...1,549,880
Ensembl chrNW_004955564:408,730...1,426,841
G
Cdk2
cyclin dependent kinase 2
ISO
RGD
PMID:16924466
RGD:2293558
NCBI chrNW_004955458:3,555,603...3,561,063
Ensembl chrNW_004955458:3,555,603...3,562,120
G
Cdk4
cyclin dependent kinase 4
susceptibility
ISO
protein:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12376462 PMID:14522882 PMID:16413469 PMID:25221644
RGD:2293577 RGD:2293581
NCBI chrNW_004955458:5,457,927...5,460,718
Ensembl chrNW_004955458:5,453,732...5,460,718
G
Cdk6
cyclin dependent kinase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25221644
NCBI chrNW_004955432:9,521,794...9,727,772
Ensembl chrNW_004955432:9,521,794...9,726,417
G
Cdkl2
cyclin dependent kinase like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25333262
NCBI chrNW_004955474:1,514,566...1,550,120
Ensembl chrNW_004955474:1,513,391...1,550,385
G
Cdkn1b
cyclin dependent kinase inhibitor 1B
treatment
ISO
protein:increased expression:mammary gland
RGD
PMID:15844214 PMID:22651929
RGD:10045559 RGD:2293626
NCBI chrNW_004955413:9,615,542...9,620,542
Ensembl chrNW_004955413:9,615,542...9,620,542
G
Cds1
CDP-diacylglycerol synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955474:5,057,833...5,104,235
Ensembl chrNW_004955474:5,057,833...5,104,235
G
Clu
clusterin
disease_progression
ISO
RGD
PMID:23099883
RGD:8699504
NCBI chrNW_004955403:50,160,598...50,175,876
Ensembl chrNW_004955403:50,160,598...50,175,876
G
Cnn3
calponin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955435:80,185...89,216
Ensembl chrNW_004955435:80,185...89,766
G
Col18a1
collagen type XVIII alpha 1 chain
severity
ISO
RGD
PMID:10766159
RGD:70690
NCBI chrNW_004955407:42,091,211...42,131,343
Ensembl chrNW_004955407:42,091,211...42,131,343
G
Col5a1
collagen type V alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955513:3,533,612...3,660,605
Ensembl chrNW_004955513:3,533,614...3,658,161
G
Csf1
colony stimulating factor 1
ISO
RGD
PMID:15205327
RGD:2293710
NCBI chrNW_004955435:13,404,236...13,423,059
Ensembl chrNW_004955435:13,404,508...13,424,247
G
Csn2
casein beta
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:9879772 PMID:16316942
RGD:2306898
NCBI chrNW_004955447:2,868,899...2,889,969
G
Csn3
casein kappa
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:16316942
RGD:2306898
NCBI chrNW_004955447:2,616,337...2,623,845
G
Csnk2a1
casein kinase 2 alpha 1
ISO
RGD
PMID:11827167
RGD:727632
NCBI chrNW_004955597:326,601...397,112
G
Ctnnb1
catenin beta 1
ISO
DNA:missense mutations: :p.S33Y, p.S45F protein:increased expression:mammary gland
RGD
PMID:17510243 PMID:18060046
RGD:2289674 RGD:2289816
NCBI chrNW_004955420:29,030,716...29,047,447
Ensembl chrNW_004955420:29,030,716...29,047,449
G
Dbi
diazepam binding inhibitor, acyl-CoA binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955459:10,342,528...10,347,700
Ensembl chrNW_004955459:10,342,251...10,347,733
G
Ddr1
discoidin domain receptor tyrosine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21283680 PMID:29298894
RGD:151347446
NCBI chrNW_004955583:820,893...838,515
Ensembl chrNW_004955583:820,931...841,654
G
Des
desmin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955453:14,039,502...14,046,572
Ensembl chrNW_004955453:14,039,502...14,047,246
G
Dio1
iodothyronine deiodinase 1
ISO
RGD
PMID:11765219
RGD:727335
NCBI chrNW_004955464:5,340,219...5,355,182
Ensembl chrNW_004955464:5,341,245...5,355,118
G
Dnmt3b
DNA methyltransferase 3 beta
treatment
ISO
RGD
PMID:24447120
RGD:9588304
NCBI chrNW_004955422:28,380,595...28,427,012
Ensembl chrNW_004955422:28,380,591...28,421,301
G
Dusp1
dual specificity phosphatase 1
treatment
ISO
RGD
PMID:20837666
RGD:5129167
NCBI chrNW_004955408:25,481,294...25,484,381
Ensembl chrNW_004955408:25,481,294...25,484,381
G
Dusp6
dual specificity phosphatase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955405:26,662,018...26,666,314
Ensembl chrNW_004955405:26,662,018...26,666,314
G
Eef1a1
eukaryotic translation elongation factor 1 alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955493:8,661,317...8,663,190
G
Efemp1
EGF containing fibulin extracellular matrix protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955424:27,181,717...27,240,067
Ensembl chrNW_004955424:27,181,099...27,240,446
G
Egfr
epidermal growth factor receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:2523869 PMID:8603490 PMID:17203220
RGD:2289979
NCBI chrNW_004955456:321,222...456,431
G
Eif5a
eukaryotic translation initiation factor 5A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955467:9,603,800...9,608,490
G
Eno1
enolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955486:4,275,371...4,287,152
Ensembl chrNW_004955486:4,274,238...4,289,809
G
Epcam
epithelial cell adhesion molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955441:14,155,084...14,167,584
Ensembl chrNW_004955441:14,155,082...14,169,161
G
Ephx1
epoxide hydrolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955520:116,363...142,983
Ensembl chrNW_004955520:116,363...128,665
G
Epo
erythropoietin
treatment
ISO
RGD
PMID:12118093
RGD:11041669
NCBI chrNW_004955573:203,875...206,078
Ensembl chrNW_004955573:203,441...206,355
G
Epor
erythropoietin receptor
treatment
ISO
RGD
PMID:12118093
RGD:11041669
NCBI chrNW_004955495:2,293,587...2,299,302
Ensembl chrNW_004955495:2,293,540...2,298,715
G
Erbb2
erb-b2 receptor tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism Androgen-dependent
RGD CTD
PMID:1913683 PMID:8603490 PMID:12150826 PMID:17203220 PMID:25221644
RGD:2289920 RGD:2289979 RGD:6482679
NCBI chrNW_004955451:14,442,816...14,456,009
Ensembl chrNW_004955451:14,442,816...14,459,379
G
Erbb3
erb-b2 receptor tyrosine kinase 3
ISO
RGD
PMID:17203220
RGD:2289979
NCBI chrNW_004955458:3,683,126...3,701,752
Ensembl chrNW_004955458:3,683,126...3,702,978
G
Erbb4
erb-b2 receptor tyrosine kinase 4
ISO
RGD
PMID:17203220
RGD:2289979
NCBI chrNW_004955457:3,177,905...4,236,152
Ensembl chrNW_004955457:3,177,991...4,228,558
G
Esr1
estrogen receptor 1
susceptibility
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:epithelial cell, nucleus
CTD RGD
PMID:11759285 PMID:15637090 PMID:18055862
RGD:2290019 RGD:8552983 RGD:8553057
NCBI chrNW_004955439:9,588,631...9,953,606
Ensembl chrNW_004955439:9,588,201...9,963,353
G
Esr2
estrogen receptor 2
treatment
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:epithelial cell, nucleus
RGD CTD
PMID:15637090 PMID:24078029
RGD:7364911 RGD:8552983
NCBI chrNW_004955466:5,587,003...5,644,765
Ensembl chrNW_004955466:5,575,088...5,638,946
G
Ezr
ezrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955439:3,701,722...3,740,345
Ensembl chrNW_004955439:3,703,013...3,740,345
G
F11r
F11 receptor
ISO
RGD
PMID:22120722
RGD:7488922
NCBI chrNW_004955468:12,764,968...12,785,956
Ensembl chrNW_004955468:12,765,874...12,785,929
G
Fabp4
fatty acid binding protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955444:141,955...146,279
Ensembl chrNW_004955444:141,840...148,467
G
Fas
Fas cell surface death receptor
ISO
RGD
PMID:18094967
RGD:2290047
NCBI chrNW_004955425:3,961,671...3,987,513
Ensembl chrNW_004955425:3,961,013...3,987,455
G
Fbxo10
F-box protein 10
ISO
RGD
PMID:17404222
RGD:1601189
NCBI chrNW_004955419:28,915,083...28,969,374
Ensembl chrNW_004955419:28,897,288...28,969,374
G
Fgf10
fibroblast growth factor 10
ISO
mRNA:increased expression:mammary gland
RGD
PMID:18421211
RGD:2292665
NCBI chrNW_004955446:18,163,117...18,244,840
Ensembl chrNW_004955446:18,163,117...18,245,199
G
Fgf7
fibroblast growth factor 7
ISO
RGD
PMID:9000125
RGD:2301094
NCBI chrNW_004955409:4,633,542...4,686,768
Ensembl chrNW_004955409:4,632,858...4,686,860
G
Fgf8
fibroblast growth factor 8
ISO
RGD
PMID:9840935
RGD:2301098
NCBI chrNW_004955485:8,517,412...8,521,732
Ensembl chrNW_004955485:8,517,412...8,521,770
G
Flt3
fms related receptor tyrosine kinase 3
ISO
RGD
PMID:10498246
RGD:2302211
NCBI chrNW_004955497:7,357,533...7,441,215
Ensembl chrNW_004955497:7,357,212...7,461,439
G
Fn1
fibronectin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955457:629,599...694,948
Ensembl chrNW_004955457:629,518...696,975
G
Frmpd1
FERM and PDZ domain containing 1
ISO
RGD
PMID:17404222
RGD:1601189
NCBI chrNW_004955419:28,717,277...28,888,486
Ensembl chrNW_004955419:28,716,494...28,888,495
G
Furin
furin, paired basic amino acid cleaving enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chrNW_004955416:14,915,031...14,947,634
Ensembl chrNW_004955416:14,936,546...14,949,252
G
Gata3
GATA binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955421:24,448,446...24,477,885
Ensembl chrNW_004955421:24,457,496...24,478,744
G
Gatm
glycine amidinotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955409:8,068,524...8,084,603
Ensembl chrNW_004955409:8,068,476...8,084,603
G
Gda
guanine deaminase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955434:983,388...1,050,413
Ensembl chrNW_004955434:983,388...1,049,948
G
Ggt1
gamma-glutamyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955455:8,082,578...8,099,523
G
Gnai2
G protein subunit alpha i2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955532:2,059,038...2,079,120
Ensembl chrNW_004955532:2,059,038...2,079,957
G
Gsk3b
glycogen synthase kinase 3 beta
treatment
ISO
RGD
PMID:28810530
RGD:13792729
NCBI chrNW_004955427:19,489,972...19,671,137
Ensembl chrNW_004955427:19,495,422...19,671,137
G
Gsn
gelsolin
ISO
mRNA:decreased expression
RGD
PMID:8895730
RGD:1599869
NCBI chrNW_004955419:6,682,202...6,733,361
Ensembl chrNW_004955419:6,682,058...6,733,361
G
Gss
glutathione synthetase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955422:26,427,581...26,483,380
Ensembl chrNW_004955422:26,427,581...26,463,781
G
H3f3b
H3 histone, family 3B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955506:6,475,336...6,478,781
Ensembl chrNW_004955506:6,474,727...6,482,244
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment
ISO
RGD
PMID:17280655
RGD:2293194
NCBI chrNW_004955466:8,000,311...8,022,497
Ensembl chrNW_004955466:8,000,044...8,022,497
G
Hmox1
heme oxygenase 1
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:16319139 PMID:23215791
RGD:10755708
NCBI chrNW_004955405:43,124,447...43,128,873
Ensembl chrNW_004955405:43,124,510...43,130,979
G
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955458:1,530,163...1,536,874
G
Hnrnpab
heterogeneous nuclear ribonucleoprotein A/B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15538050
NCBI chrNW_004955408:2,060,288...2,064,998
Ensembl chrNW_004955408:2,060,829...2,065,416
G
Hras
HRas proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism DNA:mutation: :p.G12E (rat)
CTD RGD
PMID:8185828 PMID:11376698 PMID:19652463
RGD:2314834
NCBI chrNW_004955476:11,508,446...11,510,333
Ensembl chrNW_004955476:11,508,126...11,510,333
G
Id1
inhibitor of DNA binding 1, HLH protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chrNW_004955422:29,337,969...29,339,178
Ensembl chrNW_004955422:29,337,757...29,339,178
G
Id3
inhibitor of DNA binding 3, HLH protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955452:3,537,352...3,538,921
Ensembl chrNW_004955452:3,537,021...3,560,954
G
Id4
inhibitor of DNA binding 4, HLH protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14633621
NCBI chrNW_004955483:6,598,804...6,601,496
Ensembl chrNW_004955483:6,600,867...6,602,564
G
Igf1
insulin like growth factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15217511 PMID:15528971 PMID:17584969 PMID:23342276
RGD:8549490
NCBI chrNW_004955405:37,505,830...37,582,152
Ensembl chrNW_004955405:37,512,201...37,582,152
G
Il10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14999141
NCBI chrNW_004955406:42,307,789...42,312,255
Ensembl chrNW_004955406:42,307,664...42,312,779
G
Il18bp
interleukin 18 binding protein
ISO
mRNA:increased expression:mammary gland
RGD
PMID:18959458
RGD:2313895
NCBI chrNW_004955414:19,327,828...19,332,577
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
human protein in a mouse model
RGD
PMID:21890879
RGD:6771361
NCBI chrNW_004955470:1,145,022...1,159,413
Ensembl chrNW_004955470:1,144,810...1,159,471
G
Il6st
interleukin 6 cytokine family signal transducer
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chrNW_004955446:11,790,636...11,837,734
Ensembl chrNW_004955446:11,790,444...11,835,001
G
Ilk
integrin linked kinase
ISO
late onset development of tumors in transgenic mice overexpressing human ILK in mammary glands
RGD
PMID:11704830
RGD:2301733
NCBI chrNW_004955414:22,316,243...22,322,979
Ensembl chrNW_004955414:22,316,047...22,322,979
G
Insig1
insulin induced gene 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955491:8,333,624...8,344,658
Ensembl chrNW_004955491:8,335,359...8,344,658
G
Itgb3
integrin subunit beta 3
ISO
protein:increased expression:mammary gland:
RGD
PMID:22022542
RGD:8693386
NCBI chrNW_004955478:9,788,192...9,830,254
Ensembl chrNW_004955478:9,788,149...9,823,746
G
Kdr
kinase insert domain receptor
ISO
inhibition prevents DMBA-induced atypical ductal hyperplasia and carcinoma in situ
RGD
PMID:15170218 PMID:19888452
RGD:2291936 RGD:5684399
NCBI chrNW_004955447:15,810,816...15,851,702
Ensembl chrNW_004955447:15,810,815...15,853,583
G
Kit
KIT proto-oncogene, receptor tyrosine kinase
ISO
DNA:mutation (rat)
RGD
PMID:18445266
RGD:2302172
NCBI chrNW_004955447:16,149,014...16,226,151
Ensembl chrNW_004955447:16,148,605...16,226,734
G
Kitlg
KIT ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955405:25,816,137...25,969,006
Ensembl chrNW_004955405:25,886,447...25,969,395
G
Krt5
keratin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955547:2,926,154...2,931,954
Ensembl chrNW_004955547:2,773,523...2,932,609
G
Krt7
keratin 7
ISO
RGD
PMID:8570173
RGD:2317439
NCBI chrNW_004955547:2,584,425...2,598,770
Ensembl chrNW_004955547:2,533,377...2,598,833
G
Krt71
keratin 71
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955547:2,953,853...2,962,711
Ensembl chrNW_004955547:2,953,808...3,005,228
G
Lep
leptin
treatment
ISO
RGD
PMID:22246620
RGD:8694468
NCBI chrNW_004955479:9,266,604...9,276,568
Ensembl chrNW_004955479:9,274,516...9,279,472
G
Lhcgr
luteinizing hormone/choriogonadotropin receptor
ISO
mRNA:splice variant (rat)
RGD
PMID:15044717
RGD:2302177
NCBI chrNW_004955441:15,205,883...15,263,617
Ensembl chrNW_004955441:15,207,252...15,242,914
G
Lin7a
lin-7 homolog A, crumbs cell polarity complex component
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955405:19,403,002...19,548,716
G
Lnpep
leucyl and cystinyl aminopeptidase
ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16619500
RGD:1582109
NCBI chrNW_004955418:15,631,703...15,718,711
Ensembl chrNW_004955418:15,640,143...15,718,711
G
LOC102025775
histone H2AX
treatment
ISO
RGD
PMID:22384017
RGD:7240549
NCBI chrNW_004955412:20,203,173...20,204,714
Ensembl chrNW_004955412:20,203,772...20,204,203
G
LOC102027549
serotransferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9879772 PMID:16316942
NCBI chrNW_004955501:4,801,710...4,832,025
Ensembl chrNW_004955501:4,801,885...4,831,910
G
Lpl
lipoprotein lipase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955403:43,646,084...43,672,116
Ensembl chrNW_004955403:43,646,084...43,673,967
G
Lsr
lipolysis stimulated lipoprotein receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chrNW_004955468:4,548,774...4,563,341
Ensembl chrNW_004955468:4,548,775...4,563,988
G
Map2k3
mitogen-activated protein kinase kinase 3
ISO
RGD
PMID:24233520
RGD:7495808
NCBI chrNW_004955577:1,225,033...1,249,510
Ensembl chrNW_004955577:1,237,287...1,248,541
G
Map2k7
mitogen-activated protein kinase kinase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21317887
NCBI chrNW_004955563:1,352,638...1,361,598
Ensembl chrNW_004955563:1,352,638...1,361,598
G
Mapk1
mitogen-activated protein kinase 1
treatment
ISO
RGD
PMID:29435821
RGD:13800872
NCBI chrNW_004955442:17,284,232...17,380,026
Ensembl chrNW_004955442:17,284,232...17,380,020
G
Mapk3
mitogen-activated protein kinase 3
treatment
ISO
RGD
PMID:29435821
RGD:13800872
NCBI chrNW_004955493:6,870,699...6,876,836
Ensembl chrNW_004955493:6,869,668...6,879,152
G
Mdh2
malate dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955456:14,819,406...14,833,547
Ensembl chrNW_004955456:14,819,406...14,837,142
G
Mgp
matrix Gla protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chrNW_004955413:11,614,851...11,618,090
Ensembl chrNW_004955413:11,615,078...11,618,024
G
Mif
macrophage migration inhibitory factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955455:8,367,566...8,368,460
Ensembl chrNW_004955455:8,367,566...8,368,460
G
Mmp13
matrix metallopeptidase 13
severity
ISO
RGD
PMID:18698413
RGD:2306081
NCBI chrNW_004955412:6,106,994...6,118,760
Ensembl chrNW_004955412:6,106,994...6,118,760
G
Mmp15
matrix metallopeptidase 15
ISO
mRNA:increased expression:mammary gland
RGD
PMID:15895410
RGD:2314949
NCBI chrNW_004955433:15,584,206...15,603,162
Ensembl chrNW_004955433:15,584,780...15,601,739
G
Mmp2
matrix metallopeptidase 2
treatment
ISO
protein:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19725228 PMID:23359979 PMID:28574600
RGD:2325823 RGD:8657038
NCBI chrNW_004955433:13,024,844...13,050,041
Ensembl chrNW_004955433:13,024,418...13,052,775
G
Mmp7
matrix metallopeptidase 7
onset
ISO
RGD
PMID:9850086
RGD:9685350
NCBI chrNW_004955412:5,780,772...5,792,485
Ensembl chrNW_004955412:5,778,502...5,792,445
G
Mmp9
matrix metallopeptidase 9
treatment
ISO
mRNA, protein:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19725228 PMID:21283680 PMID:23359979
RGD:2325823 RGD:8657038
NCBI chrNW_004955445:11,295,500...11,303,322
Ensembl chrNW_004955445:11,295,448...11,303,288
G
Mrc2
mannose receptor C type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955478:9,035,436...9,062,706
Ensembl chrNW_004955478:9,034,521...9,062,704
G
Mtor
mechanistic target of rapamycin kinase
ISO
RGD
PMID:22349822
RGD:10040957
NCBI chrNW_004955486:2,487,642...2,599,694
Ensembl chrNW_004955486:2,487,642...2,599,694
G
Muc1
mucin 1, cell surface associated
treatment
ISO
RGD
PMID:23015160
RGD:7349374
NCBI chrNW_004955545:1,657,728...1,662,112
G
Myc
MYC proto-oncogene, bHLH transcription factor
treatment
ISO
RGD
PMID:22384017
RGD:7240549
NCBI chrNW_004955461:2,714,022...2,718,872
Ensembl chrNW_004955461:2,714,022...2,718,982
G
Ncoa1
nuclear receptor coactivator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21080969
NCBI chrNW_004955469:6,676,780...6,892,587
Ensembl chrNW_004955469:6,794,821...6,892,566
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment
ISO
RGD
PMID:22072621
RGD:10412719
NCBI chrNW_004955403:19,510,122...19,536,428
Ensembl chrNW_004955403:19,532,103...19,535,944
G
Notch4
notch receptor 4
ISO
RGD
PMID:15531924
RGD:2299154
NCBI chrNW_004955437:658,076...679,338
G
Nsmf
NMDA receptor synaptonuclear signaling and neuronal migration factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955513:5,368,384...5,376,480
Ensembl chrNW_004955513:5,369,218...5,375,670
G
Nudt1
nudix hydrolase 1
ISO
mRNA:increased expression:mammary gland
RGD
PMID:12036445
RGD:724605
NCBI chrNW_004955460:9,678,270...9,689,106
Ensembl chrNW_004955460:9,678,270...9,689,106
G
Padi4
peptidyl arginine deiminase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955527:1,536,917...1,560,508
Ensembl chrNW_004955527:1,536,423...1,561,130
G
Pak4
p21 (RAC1) activated kinase 4
ISO
RGD
PMID:20697354
RGD:7775027
NCBI chrNW_004955468:368,721...417,614
Ensembl chrNW_004955468:367,971...378,271
G
Parp1
poly(ADP-ribose) polymerase 1
treatment
ISO
RGD
PMID:23404339
RGD:10053670
NCBI chrNW_004955489:520,875...557,609
Ensembl chrNW_004955489:520,875...557,615
G
Pcna
proliferating cell nuclear antigen
ISO
mRNA,protein:increased expression:mammary gland:
RGD
PMID:2567593
RGD:10448972
NCBI chrNW_004955415:15,744,601...15,748,910
Ensembl chrNW_004955415:15,744,601...15,749,673
G
Pcp4
Purkinje cell protein 4
ISO
mRNA,protein:increased expression:cytoplasm:
RGD
PMID:19480007
RGD:9850273
NCBI chrNW_004955407:39,853,029...39,908,151
Ensembl chrNW_004955407:39,853,034...39,908,151
G
Pdgfa
platelet derived growth factor subunit A
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:mammary gland (rat) mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:12376462 PMID:16316942
RGD:2292404 RGD:2306898
NCBI chrNW_004955460:8,328,400...8,346,755
Ensembl chrNW_004955460:8,326,891...8,346,550
G
Pebp1
phosphatidylethanolamine binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955455:13,217,012...13,222,370
G
Pgam1
phosphoglycerate mutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955507:3,562,513...3,571,400
Ensembl chrNW_004955507:3,562,513...3,571,400
G
Pgr
progesterone receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15637090
NCBI chrNW_004955412:4,643,839...4,693,478
G
Phb1
prohibitin 1
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:mammary gland
CTD RGD
PMID:12376462
RGD:2292404
NCBI chrNW_004955451:12,110,290...12,119,870
Ensembl chrNW_004955451:12,110,290...12,120,124
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chrNW_004955446:1,020,707...1,098,327
Ensembl chrNW_004955446:1,020,043...1,098,820
G
Pin1
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
ISO
RGD
PMID:22064478
RGD:8693420
NCBI chrNW_004955495:1,250,557...1,261,617
Ensembl chrNW_004955495:1,250,453...1,266,235
G
Pkm
pyruvate kinase M1/2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955450:4,907,962...4,935,179
Ensembl chrNW_004955450:4,907,788...4,936,199
G
Plau
plasminogen activator, urokinase
disease_progression
ISO
RGD
PMID:18052026
RGD:6484140
NCBI chrNW_004955437:17,995,726...18,000,542
Ensembl chrNW_004955437:17,994,537...18,000,209
G
Plk2
polo like kinase 2
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:mammary gland (rat)
CTD RGD
PMID:12376462
RGD:2292404
NCBI chrNW_004955446:9,671,090...9,676,956
Ensembl chrNW_004955446:9,671,090...9,677,188
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11137312
NCBI chrNW_004955413:30,306,563...30,366,245
Ensembl chrNW_004955413:30,307,219...30,359,500
G
Prdx2
peroxiredoxin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955415:31,880,801...31,884,453
Ensembl chrNW_004955415:31,880,588...31,884,778
G
Prl
prolactin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955483:4,495,257...4,503,377
G
Prlr
prolactin receptor
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:16316942
RGD:2306898
NCBI chrNW_004955426:20,161,406...20,326,688
Ensembl chrNW_004955426:20,168,830...20,326,840
G
Psma4
proteasome 20S subunit alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955450:925,070...932,237
Ensembl chrNW_004955450:925,542...936,653
G
Psme1
proteasome activator subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955409:36,262,114...36,264,996
Ensembl chrNW_004955409:36,262,114...36,264,994
G
Ptbp1
polypyrimidine tract binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955495:6,990,565...7,002,492
Ensembl chrNW_004955495:6,987,182...7,002,492
G
Pten
phosphatase and tensin homolog
onset
ISO
RGD
PMID:18381417
RGD:2292496
NCBI chrNW_004955425:5,007,811...5,091,829
Ensembl chrNW_004955425:5,014,147...5,091,829
G
Ptger1
prostaglandin E receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11751431
NCBI chrNW_004955415:33,063,052...33,067,580
Ensembl chrNW_004955415:33,063,052...33,067,580
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
mRNA:increased expression:breast
RGD
PMID:18279516 PMID:18676768 PMID:21623034
RGD:2300118 RGD:2300130 RGD:5135030
NCBI chrNW_004955406:25,077,988...25,086,259
Ensembl chrNW_004955406:25,079,945...25,086,171
G
Ptk2
protein tyrosine kinase 2
disease_progression
ISO
CTD Direct Evidence: therapeutic
RGD CTD
PMID:15930288 PMID:18056629 PMID:24809783
RGD:2292554 RGD:2292560
NCBI chrNW_004955461:14,337,914...14,622,779
Ensembl chrNW_004955461:14,337,914...14,556,931
G
Ptn
pleiotrophin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955494:5,580,264...5,681,848
Ensembl chrNW_004955494:5,580,422...5,684,190
G
Ptprb
protein tyrosine phosphatase receptor type B
treatment
ISO
RGD
PMID:23899555
RGD:151660352
NCBI chrNW_004955405:10,647,777...10,766,909
Ensembl chrNW_004955405:10,648,818...10,766,993
G
Ran
RAN, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chrNW_004955482:1,222,944...1,223,891
Ensembl chrNW_004955482:1,220,876...1,224,395
G
Rasa1
RAS p21 protein activator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chrNW_004955418:23,807,740...23,897,699
Ensembl chrNW_004955418:23,807,740...23,897,707
G
Rasgrf2
Ras protein specific guanine nucleotide releasing factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chrNW_004955418:28,930,666...29,126,495
Ensembl chrNW_004955418:28,930,616...29,065,110
G
Rb1
RB transcriptional corepressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14522882
NCBI chrNW_004955431:1,960,765...2,124,576
Ensembl chrNW_004955431:1,960,661...2,124,576
G
Rbp1
retinol binding protein 1
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:mammary gland (rat)
CTD RGD
PMID:12376462
RGD:2292404
NCBI chrNW_004955508:6,046,738...6,072,202
Ensembl chrNW_004955508:6,046,316...6,072,288
G
Rbp4
retinol binding protein 4
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:16316942
RGD:2306898
NCBI chrNW_004955507:112,342...120,050
Ensembl chrNW_004955507:108,669...120,584
G
Rcn1
reticulocalbin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955476:10,280,669...10,289,668
Ensembl chrNW_004955476:10,280,669...10,289,799
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
protein:decreased expression:peritoneal macrophage
RGD
PMID:16288051
RGD:2298764
NCBI chrNW_004955422:19,602,930...19,612,263
Ensembl chrNW_004955422:19,603,345...19,611,516
G
Relb
RELB proto-oncogene, NF-kB subunit
ISO
RGD
PMID:16260626
RGD:7777148
NCBI chrNW_004955555:2,060,533...2,086,229
Ensembl chrNW_004955555:2,060,533...2,086,229
G
Rnpep
arginyl aminopeptidase
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:serum
CTD RGD
PMID:16619500
RGD:1582109
NCBI chrNW_004955406:38,103,701...38,122,162
Ensembl chrNW_004955406:38,103,426...38,122,358
G
Rpl3
ribosomal protein L3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955413:25,217,777...25,224,052
Ensembl chrNW_004955413:25,217,777...25,224,052
G
Rpl6
ribosomal protein L6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955482:8,917,777...8,923,150
G
Rps14
ribosomal protein S14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955415:4,103,223...4,108,633
Ensembl chrNW_004955415:4,102,511...4,108,633
G
Rxra
retinoid X receptor alpha
ISO
RGD
PMID:16344269
RGD:1643109
NCBI chrNW_004955513:3,313,544...3,386,544
Ensembl chrNW_004955513:3,335,897...3,386,994
G
S1pr1
sphingosine-1-phosphate receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955435:5,880,266...5,882,823
Ensembl chrNW_004955435:5,880,288...5,881,436
G
Scarb1
scavenger receptor class B member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955482:4,813,502...4,836,479
Ensembl chrNW_004955482:4,813,955...4,837,392
G
Selenop
selenoprotein P
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chrNW_004955426:26,951,003...26,961,839
G
Sgk1
serum/glucocorticoid regulated kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955439:2,399,992...2,406,587
Ensembl chrNW_004955439:2,290,035...2,406,587
G
Slc12a2
solute carrier family 12 member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955415:1,138,297...1,219,241
Ensembl chrNW_004955415:1,137,327...1,219,241
G
Slc25a10
solute carrier family 25 member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955506:1,389,798...1,396,670
Ensembl chrNW_004955506:1,385,788...1,397,015
G
Sncg
synuclein gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955510:5,958,276...5,961,719
Ensembl chrNW_004955510:5,958,276...5,961,719
G
Snrpd3
small nuclear ribonucleoprotein D3 polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955455:8,021,946...8,045,325
Ensembl chrNW_004955455:8,021,946...8,046,439
G
Socs1
suppressor of cytokine signaling 1
ISO
mRNA:increased expression:mammary gland
RGD
PMID:18381452 PMID:20354188
RGD:21079418 RGD:2298899
NCBI chrNW_004955442:7,321,337...7,323,109
Ensembl chrNW_004955442:7,321,337...7,323,109
G
Socs3
suppressor of cytokine signaling 3
ISO
mRNA:increased expression:mammary gland
RGD
PMID:18381452
RGD:2298899
NCBI chrNW_004955506:4,222,455...4,225,563
Ensembl chrNW_004955506:4,222,455...4,225,563
G
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23964924
NCBI chrNW_004955439:21,209,101...21,223,538
Ensembl chrNW_004955439:21,209,101...21,224,163
G
Sox9
SRY-box transcription factor 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955478:941,684...945,563
Ensembl chrNW_004955478:940,177...945,563
G
Spint2
serine peptidase inhibitor, Kunitz type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955468:1,142,718...1,181,210
Ensembl chrNW_004955468:1,143,118...1,169,632
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15318939
NCBI chrNW_004955474:1,914,477...1,922,025
Ensembl chrNW_004955474:1,913,829...1,922,016
G
Srsf2
serine and arginine rich splicing factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955506:5,569,280...5,572,164
Ensembl chrNW_004955506:5,569,302...5,570,120
G
Stat1
signal transducer and activator of transcription 1
ISO
RGD
PMID:11325527
RGD:2291895
NCBI chrNW_004955403:8,156,660...8,192,018
Ensembl chrNW_004955403:8,156,660...8,194,762
G
Stat3
signal transducer and activator of transcription 3
ISO
mRNA:increased expression:mammary gland (rat) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16316942 PMID:17483332
RGD:2291914 RGD:2306898
NCBI chrNW_004955451:16,320,326...16,348,505
Ensembl chrNW_004955451:16,319,904...16,357,687
G
Stat5a
signal transducer and activator of transcription 5A
susceptibility
ISO
protein:increased tyrosine phosphorylation:mammary gland mRNA, protein:increased expression:mammary gland (rat) mRNA:increased expression:mammary gland (rat) CTD Direct Evidence: marker/mechanism protein:altered localization:nucleus
RGD CTD
PMID:12082622 PMID:12376462 PMID:15609129 PMID:16316942 PMID:17173897 PMID:20181624 More...
RGD:151665819 RGD:2291927 RGD:2291932 RGD:2292404 RGD:2298539 RGD:2306898
NCBI chrNW_004955451:16,305,363...16,319,219
G
Stat6
signal transducer and activator of transcription 6
ISO
DNA:gene knockout::Balb/C-derived Stat6(-/-) mice resistant to growth of implanted Balb/C mammary tumors
RGD
PMID:11086031
RGD:2298563
NCBI chrNW_004955458:4,833,417...4,847,956
Ensembl chrNW_004955458:4,833,515...4,843,273
G
Stc2
stanniocalcin 2
ISO
mRNA:increased expression:mammary gland
RGD
PMID:18959458
RGD:2313895
NCBI chrNW_004955408:25,937,174...25,950,221
Ensembl chrNW_004955408:25,934,932...25,949,399
G
Stmn1
stathmin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955452:5,387,696...5,393,337
Ensembl chrNW_004955452:5,388,150...5,391,518
G
Tdg
thymine DNA glycosylase
ISO
mRNA:increased expression:mammary gland tumor (mouse)
RGD
PMID:9794235
RGD:2317355
NCBI chrNW_004955405:38,661,687...38,680,138
Ensembl chrNW_004955405:38,673,180...38,678,481
G
Tff1
trefoil factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chrNW_004955407:39,363,693...39,365,724
G
Tgfa
transforming growth factor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8603490
NCBI chrNW_004955424:14,616,390...14,709,723
Ensembl chrNW_004955424:14,616,259...14,710,183
G
Tgfb1
transforming growth factor beta 1
ISO
RGD
PMID:8466857
RGD:7394797
NCBI chrNW_004955555:274,405...288,441
Ensembl chrNW_004955555:270,652...288,441
G
Tgfbr1
transforming growth factor beta receptor 1
ISO
RGD
PMID:12808151
RGD:737735
NCBI chrNW_004955419:26,490,899...26,546,349
Ensembl chrNW_004955419:26,490,899...26,547,017
G
Tgfbr2
transforming growth factor beta receptor 2
ISO
RGD
PMID:12808151
RGD:737735
NCBI chrNW_004955430:21,919,338...21,999,688
Ensembl chrNW_004955430:21,932,553...22,001,837
G
Thbs1
thrombospondin 1
ISO
mRNA:increased expression:mammary gland
RGD
PMID:15459484
RGD:1626167
NCBI chrNW_004955416:6,490,034...6,506,419
Ensembl chrNW_004955416:6,489,451...6,506,419
G
Thrsp
thyroid hormone responsive
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955414:13,879,095...13,883,378
G
Tkt
transketolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955430:3,178,830...3,193,241
Ensembl chrNW_004955430:3,178,830...3,193,345
G
Tle4
TLE family member 4, transcriptional corepressor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955530:3,795,336...3,932,596
Ensembl chrNW_004955530:3,794,955...3,933,399
G
Tnf
tumor necrosis factor
ISO
RGD
PMID:19755514
RGD:7401185
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
G
Tnfsf10
TNF superfamily member 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21252285
NCBI chrNW_004955420:2,550,392...2,566,448
Ensembl chrNW_004955420:2,549,142...2,566,564
G
Tp53
tumor protein p53
disease_progression
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17470299 PMID:18092324 PMID:24809783
RGD:2290539 RGD:2290577
NCBI chrNW_004955467:9,241,391...9,256,716
Ensembl chrNW_004955467:9,252,130...9,255,928
G
Tpm3
tropomyosin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chrNW_004955545:715,860...746,580
Ensembl chrNW_004955545:715,280...746,575
G
Trps1
transcriptional repressor GATA binding 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955417:21,674,545...21,913,137
Ensembl chrNW_004955417:21,680,116...21,913,173
G
Tsc22d1
TSC22 domain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955518:2,322,566...2,451,519
Ensembl chrNW_004955518:2,321,226...2,450,812
G
Txnip
thioredoxin interacting protein
severity
ISO
mRNA:decreased expression:mammary gland
RGD
PMID:15170812
RGD:1642758
NCBI chrNW_004955568:103,801...107,791
Ensembl chrNW_004955568:103,762...107,785
G
Tyms
thymidylate synthetase
ISO
RGD
PMID:9635926
RGD:2315839
NCBI chrNW_004955402:9,295,862...9,304,952
Ensembl chrNW_004955402:9,296,321...9,306,631
G
Ube2i
ubiquitin conjugating enzyme E2 I
ISO
MCF-7 human breast cancer cell tumors grown in nude mice CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15735760 PMID:16316942
RGD:2301345
NCBI chrNW_004955442:15,902,026...15,913,033
Ensembl chrNW_004955442:15,901,980...15,913,037
G
Ucp2
uncoupling protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955414:17,592,914...17,596,477
Ensembl chrNW_004955414:17,592,914...17,596,477
G
Vamp8
vesicle associated membrane protein 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chrNW_004955424:1,922,830...1,926,844
Ensembl chrNW_004955424:1,923,092...1,926,728
G
Vdr
vitamin D receptor
ISO
RGD
PMID:15333467
RGD:8158073
NCBI chrNW_004955500:6,745,725...6,798,052
Ensembl chrNW_004955500:6,745,678...6,798,048
G
Vegfa
vascular endothelial growth factor A
treatment
ISO
human protein in a mouse model
RGD
PMID:21890879
RGD:6771361
NCBI chrNW_004955437:9,527,445...9,541,908
G
Wnt1
Wnt family member 1
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298848 RGD:2298863
NCBI chrNW_004955500:7,797,063...7,811,142
Ensembl chrNW_004955500:7,797,060...7,811,167
G
Wnt2
Wnt family member 2
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298848 RGD:2298863
NCBI chrNW_004955432:22,988,208...23,024,530
Ensembl chrNW_004955432:22,984,170...23,027,705
G
Wnt3a
Wnt family member 3A
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298848 RGD:2298863
NCBI chrNW_004955581:351,375...382,541
Ensembl chrNW_004955581:350,889...382,541
G
Wnt5b
Wnt family member 5B
no_association
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298848 RGD:2298863
NCBI chrNW_004955454:4,158,648...4,192,709
Ensembl chrNW_004955454:4,178,609...4,192,710
G
Wnt6
Wnt family member 6
no_association
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298848 RGD:2298863
NCBI chrNW_004955453:14,547,427...14,560,001
Ensembl chrNW_004955453:14,545,700...14,560,976
G
Wnt7a
Wnt family member 7A
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298848 RGD:2298863
NCBI chrNW_004955429:12,647,993...12,693,998
Ensembl chrNW_004955429:12,647,993...12,694,895
G
Wnt7b
Wnt family member 7B
no_association
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298848 RGD:2298863
NCBI chrNW_004955413:30,146,185...30,185,693
Ensembl chrNW_004955413:30,144,869...30,181,791
G
Xiap
X-linked inhibitor of apoptosis
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12766084
NCBI chrNW_004955473:10,823,795...10,878,256
Ensembl chrNW_004955473:10,827,435...10,840,604
G
Xrcc3
X-ray repair cross complementing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chrNW_004955538:2,499,297...2,511,898
Ensembl chrNW_004955538:2,501,607...2,509,778
G
Ywhaz
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chrNW_004955417:16,047,263...16,070,506
Ensembl chrNW_004955417:16,047,263...16,072,854
G
Dpyd
dihydropyrimidine dehydrogenase
treatment
ISO
RGD
PMID:8138551
RGD:11251753
NCBI chrNW_004955435:2,007,185...2,800,907
Ensembl chrNW_004955435:2,007,185...2,766,138
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
disease
13423
disease of cellular proliferation
6344
Experimental Neoplasms
406
Carcinoma 256, Walker
0
Carcinoma, Brown-Pearce
0
Carcinoma, Krebs 2
0
Carcinoma, Lewis Lung
11
Ehrlich tumor carcinoma
3
Experimental Leukemia +
7
Experimental Liver Neoplasms
107
Experimental Melanoma
22
Experimental Sarcoma +
9
Mammary Neoplasms, Experimental
260
Path 2
disease
13423
Animal Diseases
1171
Animal Disease Models
1134
Experimental Neoplasms
406
Carcinoma 256, Walker
0
Carcinoma, Brown-Pearce
0
Carcinoma, Krebs 2
0
Carcinoma, Lewis Lung
11
Ehrlich tumor carcinoma
3
Experimental Leukemia +
7
Experimental Liver Neoplasms
107
Experimental Melanoma
22
Experimental Sarcoma +
9
Mammary Neoplasms, Experimental
260